Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.
By A. Schinkel, J. Jonker. Advanced Drug Delivery Reviews, 2003
1,556 citations recorded by the source corpus.
Subfields: Oncology, Pharmacology, Surgery
View Paper: https://www.semanticscholar.org/paper/a3e4ff331bd3c90fd82810283e3168dd0c99cef0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Pharmacology
In Surgery
Citations in the corpus
- Targeting multidrug resistance in cancer (2006, background): “Transported substrates include cytotoxic drugs, toxins and carcinogens found in food products, as well as endogenous compound”
- Modelling of the blood–brain barrier in drug discovery and development (2007, background): “Thus far, the mammalian MRP family consists of nine protein”
- ABC multidrug transporters: structure, function and role in chemoresistance. (2008, background): “Several of these proteins are multidrug efflux pumps that not only protect the body from exogenous toxins, but also play an important role in the uptake and distribution of therapeutic drugs [4].”
- Drug resistance in brain diseases and the role of drug efflux transporters (2005, background): “All cells express efflux transporters that protect them from endogenous or exogenous toxic substance”
- Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions (2006, background): “BMVEC possesses the so-called multidrug resistance (MDR) proteins, a phenotype first described for chemotherapy-resistant cancer cells that overexpressed one of these efflux transporters, P-gp (Schinkel and Jonker 2003).”